Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3.

Saved in:
Bibliographic Details
Title: Hsa-miR-100-5p promotes the development and progression of gastric cancer through targeted atypical chemokine receptor 3.
Authors: Wang XL; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China., Jiang JC; Department of Nursing, Hai'an Traditional Chinese Medicine Hospital Nantong 226600, Jiangsu, China., Song JY; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China., Ni JY; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China., Song L; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China., Xiao JZ; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China., Fu D; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China.; Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai 200025, China., Chen ZY; Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai 200025, China., Cao YF; Department of Oncology, Affiliated Tumor Hospital of Nantong University Nantong 226631, Jiangsu, China.
Source: International journal of clinical and experimental pathology [Int J Clin Exp Pathol] 2025 Jul 15; Vol. 18 (7), pp. 302-316. Date of Electronic Publication: 2025 Jul 15 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101480565 Publication Model: eCollection Cited Medium: Internet ISSN: 1936-2625 (Electronic) Linking ISSN: 19362625 NLM ISO Abbreviation: Int J Clin Exp Pathol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1936-2625
DOI:10.62347/SBGT4820